Clinical Trials Directory

Trials / Conditions / Neurodegenerative Diseases

Neurodegenerative Diseases

150 registered clinical trials studyying Neurodegenerative Diseases46 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingNovel Technologies to Measure Vision-related Quality of Life
NCT07489898
Nisha Nixon
Not Yet RecruitingStudy on the Application of ¹⁸F-FCOB04, a MAO-B Targeted PET Imaging Agent, in Neurodegenerative Diseases
NCT07470710
Peking Union Medical College HospitalEARLY_Phase 1
RecruitingSlowing Cognitive Decline in Alpha-synucleinopathies by Enhancing Physical Activity
NCT07324330
University Hospital, BonnN/A
RecruitingValidation of the VIRADIA App for Neurological and Cognitive Diagnostics in Virtual Reality
NCT07268079
Gametherapy
Not Yet RecruitingClinical Research on Stem Cell Therapy for Parkinson's Disease
NCT07232147
Liaoning Medical Diagnosis and Treatment Technology Research and Development Co., Ltd.Phase 1
Active Not RecruitingDecision-making, Ethical Consent, and Interactive Dialogue in Ongoing Neurocognitive Decline - DECISION
NCT07514520
Ludwig-Maximilians - University of Munich
Not Yet RecruitingEstablish the First International Database on Semi-quantitative Values Obtained in Scintigraphy With Datscan®
NCT06828705
Central Hospital, Nancy, France
Not Yet RecruitingSlow-SPEED: Slowing Parkinson's Early Through Exercise Dosage
NCT06993142
Radboud University Medical CenterN/A
RecruitingSaliva and Extracellular Vesicles for Neurodegenerative Diseases
NCT06869135
Fondazione Don Carlo Gnocchi Onlus
RecruitingSleep Disordered Breathing and Multimorbidity: The Xiangya SDB Cohort Study
NCT06755840
Xiangya Hospital of Central South University
Enrolling By InvitationSimulation-informed Modelling and Personalized Evaluation (SIMPLE) in Ageing Populations
NCT06572332
Chinese University of Hong Kong
CompletedNAD+ Oral Supplement Pilot Intervention in Adult Females
NCT06579209
University of Rhode IslandN/A
RecruitingA Phase 3 Study of NTLA-2001 in ATTRv-PN
NCT06672237
Intellia TherapeuticsPhase 3
RecruitingNeurodegenerative Diseases Progression Markers (MARKERS-NDD)
NCT06596746
Casa di Cura San Raffaele Cassino
Not Yet RecruitingMultimodal Markers of Neurodegenerative Disorders at Presymptomatic Stages
NCT06516016
Paris Brain Institute (ICM)
RecruitingA Low-Cost Balance Training Platform Using Augmented Reality in Neurorehabilitation: a Usability Study
NCT06627387
Hospital Universitari Vall d'Hebron Research InstituteN/A
Not Yet RecruitingCognitive Impairment Cohort Study of the Elderly Population in YuGarden
NCT06325527
Ruijin Hospital
RecruitingBlood And Tears in Alzheimer's Disease
NCT06567431
Danish Dementia Research Centre
UnknownThe Clinical Impact of the Novel Alzheimer's Blood-based Biomarkers
NCT06246019
Hospital del Mar Research Institute (IMIM)
RecruitingSlow-SPEED-NL: Slowing Parkinson's Early Through Exercise Dosage-Netherlands
NCT06193252
Radboud University Medical CenterN/A
Active Not RecruitingAMX0035 and Progressive Supranuclear Palsy
NCT06122662
Amylyx Pharmaceuticals Inc.Phase 2 / Phase 3
TerminatedContinuation Study for Latozinemab
NCT06111014
Alector Inc.Phase 3
Enrolling By InvitationNormal Chinese Lifespan Brain Charts Initiative (NCLBCI)
NCT06643858
Beijing Tiantan Hospital
RecruitingMemory Deterioration in Alzheimer Disease
NCT07118137
Norwegian University of Science and Technology
UnknownCSF1R PET Probe [18F]CSF-23 in Alzheimer's Disease Brain Imaging
NCT06148233
Huashan HospitalN/A
UnknownSingle Arm Clinical Trial of Small Molecule Natural Flavonoid Compounds for Intervention in Neurodegenerative
NCT05947409
Mei HanN/A
RecruitingAllopregnanolone Regenerative Therapeutic for Mild Alzheimer's Disease
NCT04838301
University of ArizonaPhase 2
UnknownRandomized Control Trial of Small-Molecule Natural Flavonoids Intervention for Neurodegenerative Diseases
NCT05947396
Mei HanN/A
Not Yet RecruitingClinical Effect of Acupuncture in Neurodegenerative Diseases on Traumatic Brain Injury Patients
NCT05839132
China Medical University HospitalN/A
WithdrawnStudy to Assess the Efficacy of XPro1595 in Patients With Mild Cognitive Impairment With Biomarkers of Inflamm
NCT05321498
Inmune Bio, Inc.Phase 2
RecruitingStudy to Evaluate the Efficacy and Safety of ATNC-MDD V1(TMS With Cognitive Training) in Mild Alzheimer's Deme
NCT06088121
Advanced Technology & CommunicationsN/A
RecruitingCognitive Reserve and Response to Speech-Language Intervention in Bilingual Speakers With Primary Progressive
NCT05741853
University of Texas at AustinN/A
RecruitingEffects of Long Term Ventilation Support on the Quality of Life of ALS Patients and Their Families
NCT05744310
Haukeland University HospitalN/A
CompletedHome-Based Exercise in Primary Progressive Aphasia (HEPPA)
NCT06181500
Montreal Heart InstituteN/A
CompletedA First Time in Human Study of SNP318 as a Treatment for Neurodegenerative Diseases Including Alzheimer's Dise
NCT05792163
SciNeuroPhase 1
UnknownLongitudinal Tracking of Patients Diagnosed With Neurodegenerative Movement Disorders
NCT05486806
Brigham and Women's Hospital
Active Not RecruitingA Study of Different Donanemab (LY3002813) Dosing Regimens in Adults With Early Alzheimer's Disease (TRAILBLAZ
NCT05738486
Eli Lilly and CompanyPhase 3
TerminatedAn Open-Label Extension of XPro1595 in Patients With Alzheimer's Disease
NCT05522387
Inmune Bio, Inc.Phase 2
RecruitingAdherence to Long-term Exoskeleton Rehabilitation to Treat Lower Limb Weakness and / or Deficiencies in Adult
NCT06538974
WandercraftN/A
Active Not RecruitingDevelopment and Test of a Headset for BCI Until Obtaining an Efficient and Comfortable System That Can be Used
NCT04380649
Centre Hospitalier Universitaire de NiceN/A
RecruitingHome Exercise for Individuals with Neurodegenerative Disease
NCT05443906
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.N/A
UnknownTau And Connectomics In TES Study
NCT05490576
Macquarie University, AustraliaPhase 1
WithdrawnExperimentation of a Personalized Physical Self-education Program at Home: Feasibility Study (PROSOL TELEKINEC
NCT05597592
Centre Hospitalier Universitaire de NiceN/A
RecruitingCharacterization of the Serotonin 2A Receptor Selective PET Tracer [18F]MH.MZ in Patients With Neurodegenerati
NCT05357612
Vanderbilt University Medical CenterPhase 4
Not Yet RecruitingCognitive Impairment Cohort Study of the Elderly Population in SheMountain
NCT05667935
Ruijin Hospital
RecruitingProbiotics in Mild Alzheimer's Disease
NCT06181513
University of NicosiaEARLY_Phase 1
CompletedUsing Neuroimaging to Early Diagnose Alzheimer's Disease Through Hippocampal Atrophy Assessment
NCT06965816
Centre Hospitalier de Saint-Denis
UnknownClinical Study of [18F] PM-PBB3 PET Imaging of Tau Protein in Neurodegenerative Diseases
NCT06344845
Peking Union Medical College HospitalN/A
RecruitingA Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5
NCT05508789
Eli Lilly and CompanyPhase 3
CompletedInvestigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases
NCT05538455
Casa di Cura Privata del Policlinico SpAN/A
CompletedThe Role of Humanoid Robot in Neuropsychological Assessment and Cognitive Training.
NCT05788133
IRCCS Centro Neurolesi Bonino PulejoN/A
CompletedExtension of AOC 1001-CS1 (MARINA) Study in Adult Myotonic Dystrophy Type 1 (DM1) Patients
NCT05479981
Avidity Biosciences, Inc.Phase 2
UnknownRole of Saffron and Chamomile in the Management of Parkinson's Disease
NCT05696665
Jinnah Postgraduate Medical CentreN/A
RecruitingSerotonin Release in Premotor and Motor PD
NCT05516732
University of Exeter
RecruitingMolecular and Functional Imaging in Monogenic PD.
NCT05518617
University of Exeter
CompletedAssessing a Novel Virtual Environment That Assists With Activities of Daily Living
NCT05418296
mandyN/A
RecruitingPassive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide Ribo
NCT05245903
Mclean Hospital
RecruitingHereditary Spastic Paraplegia Genomic Sequencing Initiative (HSPseq)
NCT05354622
Boston Children's Hospital
CompletedHIFT in People With Parkinson's Disease
NCT05482776
University of ValenciaN/A
UnknownImmunohistochemical Study of Neurodegenerative Diseases
NCT05518409
First Affiliated Hospital of Zhejiang UniversityN/A
UnknownClearance Mechanisms in Atypical Neurodegenerative Diseases
NCT05317871
Ludwig-Maximilians - University of Munich
RecruitingExploring the Recovery Function of Sleep in Neurodegeneration
NCT05402488
University of ZurichN/A
CompletedClinical Application of the Prototype J-PET Device
NCT06211803
Jagiellonian University
RecruitingShanghai At Risk for Alzheimer's Disease: a Cohort Study
NCT05597410
Ruijin Hospital
CompletedA Study of XPro1595 in Patients With Early Alzheimer's Disease With Biomarkers of Inflammation
NCT05318976
Inmune Bio, Inc.Phase 2
RecruitingMolecular Imaging of Inflammation in Parkinson's Disease Using LPS and TSPO-PET/MR
NCT05205291
University of Exeter
Unknown[18F]MC225-PET in Neurodegenerative Disease
NCT05853471
University Medical Center GroningenPhase 1 / Phase 2
CompletedRisk of Developing Dementia and Associated Factors in Patients With Normal Brain FDG PET
NCT04804722
Central Hospital, Nancy, France
CompletedHarmony at Home: A Pilot Telehealth Program for Rural ADRD Caregivers
NCT05202223
Elizabeth K RhodusN/A
Active Not RecruitingSociodemographic Factors and Criminal Behaviour Preceding Neurodegenerative Disease - Retrospective Register S
NCT06209515
Kuopio University Hospital
CompletedUnderstanding Ayurveda Disease Conditions and Treatment Responses
NCT06167226
Ayurai Private Limited
UnknownRole and Mechanism of Probiotics in Improving Motor Symptoms in Mild to Moderate Parkinson's Disease
NCT04871464
Beijing Friendship HospitalPhase 4
CompletedA FIH Study to Assess the Safety and Tolerability of NS Intravenous NS101 Infusion
NCT05143463
Neuracle Science Co., LTD.Phase 1
RecruitingLongitudinal Investigation of I2BS in PD
NCT05516719
University of Exeter
CompletedEvaluation of the Peripheral Nerve Ultrasound as a Diagnostic Tool in CANVAS Neuropathies
NCT05095870
Centre Hospitalier Universitaire de Nīmes
UnknownCerebrovascular Reactivity and Oxygen Metabolism as Markers of Neurodegeneration After Traumatic Brain Injury
NCT04820881
Washington D.C. Veterans Affairs Medical Center
UnknownLong-term Follow-up in Severe Traumatic Brain Injury
NCT05235802
Karolinska University Hospital
CompletedPilot Pragmatic Clinical Trial to Embed Tele-Savvy Into Health Care Systems
NCT05080777
UConn HealthN/A
RecruitingNeurofilament Light Chain And Voice Acoustic Analyses In Dementia Diagnosis
NCT06339190
Monash University
CompletedDopaminergic Therapy for Frontotemporal Dementia Patients
NCT04937452
I.R.C.C.S. Fondazione Santa LuciaPhase 2
CompletedValidation of the NeuroTec Loft
NCT04793555
University of BernN/A
CompletedPersonalized Parkinson Project PSP Cohort
NCT05501431
Radboud University Medical Center
CompletedThe Efficacy of VESPA 2.0 for Cognitive Rehabilitation in Patients With Mild Cognitive Impairment
NCT06281314
IRCCS Centro Neurolesi Bonino PulejoN/A
CompletedA Bridging Study on Efficacy and Safety of [18F]Florbetaben PET for Diagnosis of Alzheimer Disease Subjects in
NCT05527288
Sinotau Pharmaceutical GroupN/A
CompletedExploratory Evaluation of [11C]MPC6827
NCT04575727
Columbia UniversityEARLY_Phase 1
UnknownNear-Infrared Laser Stimulation for Various Neurological Conditions
NCT04489082
Neurological Associates of West Los AngelesN/A
UnknownIntensive Multidisciplinary Rehabilitation and Biomarkers in Parkinson's Disease
NCT05452655
Fondazione Don Carlo Gnocchi OnlusN/A
Active Not RecruitingThe Personalized Parkinson Project De Novo Cohort
NCT04985539
Radboud University Medical Center
CompletedA First in Human Study to Assess the Safety, Tolerability and Pharmacokinetics of ONO-2808-01 in Healthy Parti
NCT04578028
Ono Pharmaceutical Co., Ltd.Phase 1
CompletedBig Data and Genomic Imaging for the Development of Biomarkers and Nanovector Drugs Innovative for Diagnosis a
NCT05761535
IRCCS SYNLAB SDN
UnknownPilot Study About Extra Virgin Olive Oil "Coratina" in Mild Cognitive Impairment and Alzheimer's Disease Patie
NCT04229186
University of Bari Aldo MoroN/A
SuspendedFocused Ultrasound and Exosomes to Treat Depression, Anxiety, and Dementias
NCT04202770
Neurological Associates of West Los AngelesN/A
UnknownStudy of Neurodegenerative Diseases Induced Stem Cells in Patients and Healthy Family Controls.
NCT03682458
Neuromed IRCCS
UnknownNeurodegenerative Diseases Registry
NCT04472130
Vincent Mok
UnknownInflammation and Neurocognitive Damage Markers in Elderly People With Obstructive Sleep Apnea
NCT04882020
Hospital de Clinicas de Porto Alegre
CompletedMetabolomics Profiling Research of Human Cerebrospinal Fluid in Aging Process
NCT04315038
Chang Gung Memorial Hospital
CompletedNeuropsychological Indicators of SCD Progression
NCT04880252
Centre Hospitalier Universitaire, Amiens
CompletedNAD-supplementation in Drug naïve Parkinson's Disease
NCT03816020
Haukeland University HospitalN/A
UnknownCcf mtDNA as a Neurodegenerative Biomarker
NCT03938909
Neuromed IRCCS
TerminatedMindfulness for Alzheimer Caregivers
NCT03858283
Universidad Miguel Hernandez de ElcheN/A
RecruitingTranslocator Protein PET/CT in Various TSPO-Related Disease
NCT06725719
Tianjin Medical University
CompletedSupporting Elderly People With Cognitive Impairment During and After Hospital Stays- Intersectoral Care Manage
NCT03359408
German Center for Neurodegenerative Diseases (DZNE)N/A
UnknownCorrelation Between Melatonin Levels in Different Biological Fluids
NCT05784090
Istituto Auxologico Italiano
CompletedA Double-Blind, Placebo-Controlled Safety and Efficacy Study of NA-831
NCT03538522
Biomed Industries, Inc.Phase 2
CompletedIncreasing Diagnosis Rates While Reducing Examination Time: Can MR Fingerprinting Deliver on Its Promise?
NCT06251830
IRCCS Fondazione Stella Maris
RecruitingTau PET/CT in Various Tau-Related Disease Patients
NCT06690983
Tianjin Medical University
CompletedCiticoline Concentration in Human Vitreous
NCT04003090
Istituto di Ricerca Neuroftalmologia S.r.l.N/A
CompletedSmell, Voice and Nasal Swabs as Markers for Neuro-degenerative Disorders
NCT03299062
University of ArkansasN/A
CompletedStriatal Dopamine Transmission in Individuals With Isolated Rapid Eye Movement Sleep With Atonia: a Search for
NCT03353207
Chinese University of Hong Kong
CompletedClinical Study to Test the Safety of CDNF by Brain Infusion in Patients With Parkinson's Disease
NCT03295786
Herantis Pharma Plc.Phase 1 / Phase 2
UnknownCommunity-based Cohort of Functional Decline in Subjective Cognitive Complaint Elderly
NCT04265482
Geroscience Center for Brain Health and Metabolism (Gero)
RecruitingSystematic Assessment of Laryngopharyngeal Function in Patients With Neurodegenerative Diseases
NCT04706234
Kliniken Beelitz GmbH
WithdrawnContribution of the Therapies of Resolution of Problem in the Care of the Natural Caregivers of Patients Affec
NCT03438513
University Hospital, Montpellier
CompletedAMX0035 in Patients With Amyotrophic Lateral Sclerosis (ALS)
NCT03127514
Amylyx Pharmaceuticals Inc.Phase 2
CompletedSafety and Efficacy Study of VY-AADC01 for Advanced Parkinson's Disease
NCT03065192
Neurocrine BiosciencesPhase 1
CompletedEvaluation of the Organization of Continuity of Care for Home Hospice Patients by Four Parisian Health Network
NCT03336489
Fondation Ophtalmologique Adolphe de Rothschild
RecruitingNeurologic Stem Cell Treatment Study
NCT02795052
MD Stem CellsN/A
Completed[18F]THK-5351 Positron Emission Computed Tomography Study of Normal, Mild Cognitive Impairment, Alzheimer's Di
NCT02656498
Jae Seung KimPhase 2
CompletedStudy of Cerebral Glucose Metabolism in Neurodegenerative Diseases and Head Trauma
NCT06180213
IRCCS San Raffaele
CompletedCNS Tau Kinetics in Healthy Aging and Alzheimer's Disease
NCT03938870
Washington University School of Medicine
Active Not RecruitingMobile Parkinson Observatory for Worldwide, Evidence-based Research (mPower)
NCT02696603
Sage BionetworksN/A
CompletedStudy Assessing Safety and Therapeutic Activity of AFFITOPE® PD01A and PD03A in Patients With Early MSA
NCT02270489
Affiris AGPhase 1
CompletedStudy Assessing Tolerability and Safety of AFFITOPE® PD03A in Patients With Early Parkinson's Disease
NCT02267434
Affiris AGPhase 1
UnknownQuantification of Transition Metals
NCT02222779
University of Cologne
CompletedVA Cultivating Access to Resources, Education, and Skills for Dementia Caregivers
NCT02106065
VA Office of Research and DevelopmentN/A
RecruitingObservational Pharmaco-Epidemiology Research & Analysis
NCT03813862
Epividian
CompletedYogic Breathing Changes Salivary Components
NCT02108769
Medical University of South CarolinaN/A
CompletedSafety and Clinical Outcomes Study: SVF Deployment for Orthopedic, Neurologic, Urologic, and Cardio-pulmonary
NCT01953523
Elliot LanderN/A
RecruitingNew CSF Biomarkers for Alzheimer's Disease
NCT03621839
Central Hospital, Nancy, France
RecruitingBeta Amyloid PET/CT in Various Aβ-Related Disease
NCT06725706
Tianjin Medical University
UnknownThe Long-Term Safety and Efficacy Follow-Up Study of Subjects Who Completed the Phase I Clinical Trial of Neur
NCT01696591
Duk Lyul Na
CompletedA Longitudinal Study of Amyotrophic Lateral Sclerosis (ALS) Biomarkers
NCT01495390
Massachusetts General Hospital
CompletedEvaluation of Web-based Training to Educate Physicians in the Methods of Interpreting Florbetapir-PET Scans
NCT01550549
Avid RadiopharmaceuticalsN/A
CompletedEffect of Undenatured Cysteine-Rich Whey Protein Isolate (HMS 90®) in Patients With Parkinson's Disease
NCT01662414
Chulalongkorn UniversityPhase 4
CompletedObservational Study of the Prevalence of CCSVI in Multiple Sclerosis and in Other Neurodegenerative Diseases
NCT01384825
Fondazione Italiana Sclerosi Multipla
UnknownElectronic Nose for Diagnosis of Neurodegenerative Diseases Via Breath Samples
NCT01291550
Rambam Health Care Campus
WithdrawnEstablishment of a Human Tissue Bank for Studying the Microbial Etiology of Neurodegenerative Diseases
NCT01954875
Wake Forest University Health Sciences
CompletedClinical Evaluation of Florbetapir F 18 (18F-AV-45)
NCT01518374
Avid RadiopharmaceuticalsPhase 2
CompletedHealth Technology Assessment of Diagnostic Approaches in Alzheimer's Disease
NCT01450891
Maastricht University Medical Center
CompletedResource Use and Disease Course in Dementia (REDIC)
NCT01920100
Sykehuset Innlandet HF
CompletedDatabase of Positon Emission Tomography (PET) Digital Brain Exams, in 50th Age of Patients
NCT04163276
Central Hospital, Nancy, France
TerminatedVisual Motor Coordination
NCT00568243
National Eye Institute (NEI)
CompletedFollow Up Safety Study of SCH 420814 in Subjects With Parkinson's Disease (P05175)
NCT00537017
Merck Sharp & Dohme LLCPhase 2
CompletedDyskinesia in Parkinson's Disease (Study P04501)
NCT00406029
Merck Sharp & Dohme LLCPhase 2
TerminatedQuantitative Measurement of Nutritional Substrate Utilization in Patients With Amyotrophic Lateral Sclerosis (
NCT00714220
Drexel University College of Medicine
CompletedBiodistribution and Safety of a Radiopharmaceutical in Healthy Subjects
NCT00316797
Institute for Neurodegenerative DisordersPhase 1
CompletedMagnetic Resonance Imaging (MRI) of Brain Iron in Neurodegenerative Disease
NCT00249080
Albany Medical College
CompletedThe Moli-sani Study
NCT03242109
Neuromed IRCCS
UnknownNorthern Sweden Health and Disease Study
NCT03426488
Umeå University
UnknownPromoting Informed Decision Making Through Advance Care Planning
NCT02211287
Queen's University, BelfastN/A